Updates‎ > ‎

"Compositions and methods for treating glioma" US and Japan patent

posted Mar 18, 2019, 5:26 AM by Kacper Walentynowicz   [ updated Mar 18, 2019, 5:26 AM ]
Prof Kaminska has received a patent for innovative method employing synthetic peptides that block crosstalk between tumor cells and microenvironment for brain tumor therapy. Tumor cells produce various factors that influence surrounding non-tumor cells and transform them into tumor-supporting phenotype. The synthetic peptides target tumor secreting GM-CSF (granulocyte-macrophage colony-stimulating factor) and proteins acting through integrin receptors through RGD motifs. Application of these peptides block tumor invasion and growth in vivo.

The recepiant of the patent are Prof. Bożena Kamińska, Dr Małgorzata Sielska, Dr Paweł Wiśniewski, and Dr Aleksandra Ellert-Miklaszewska with ownership to Glia Sp. z o.o. Patent is also under consideration in Europe, Israel, and Canada.